Skip to main content
Premium Trial:

Request an Annual Quote

Michael Taylor

Premium
Cequent Pharmaceuticals has appointed Michael Taylor to its board of directors.
 
Taylor is president and CEO of Ensemble Discovery, a biotechnology firm developing drugs and assays. Previously, he was senior vice president for Pfizer’s global research and development division.
 
He holds a PhD in medicinal chemistry from the State University of New York at Buffalo.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.